For: | Tovo CV, de Mattos AZ, Coral GP, Sartori GDP, Nogueira LV, Both GT, Villela-Nogueira CA, de Mattos AA. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis. World J Gastroenterol 2023; 29(2): 343-356 [PMID: 36687125 DOI: 10.3748/wjg.v29.i2.343] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i2/343.htm |
Number | Citing Articles |
1 |
Madalina-Gabriela Taru, Monica Lupsor-Platon. Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography. Cancers 2023; 15(16): 4097 doi: 10.3390/cancers15164097
|
2 |
Cornelius J Fernandez, Lakshmi Nagendra, Joseph M Pappachan. Metabolic Dysfunction-associated Fatty Liver Disease: An Urgent Call for Global Action. touchREVIEWS in Endocrinology 2023; 20(1): 1 doi: 10.17925/EE.2023.20.1.1
|
3 |
Junyu Wu, Hor-Yue Tan, Yau-Tuen Chan, Yuanjun Lu, Zixin Feng, Hongchao Yuan, Cheng Zhang, Yibin Feng, Ning Wang. PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-02967-3
|
4 |
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, Adriano Cressoni Araújo, Ricardo de Alvares Goulart, Marcelo Dib Bechara, Lucas Fornari Laurindo, Nahum Méndez-Sánchez, Sandra Maria Barbalho. Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. International Journal of Molecular Sciences 2024; 25(7): 3694 doi: 10.3390/ijms25073694
|
5 |
Centura R. Anbarasu, Sophia Williams-Perez, Ernest R. Camp, Derek J. Erstad. Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. Cancers 2024; 16(16): 2773 doi: 10.3390/cancers16162773
|
6 |
Abraham Koshy. Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024. Journal of Clinical and Experimental Hepatology 2025; 15(1): 102406 doi: 10.1016/j.jceh.2024.102406
|
7 |
Gianni TESTINO, Rinaldo PELLICANO. Corrected and republished from: Metabolic associated liver disease. Panminerva Medica 2023; 65(3) doi: 10.23736/S0031-0808.23.04850-4
|
8 |
Cristiane Valle TOVO, Carolina Rossatto RIBAS, Giovana Dal Pozzo SARTORI, Gabriela Perdomo CORAL, Eiji SUWA, Angelo Alves de MATTOS. SPONTANEOUS REGRESSION OF HEPATOCELLULAR CARCINOMA: FOCUSING IN THE ASSOCIATED RISK FACTORS. Arquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612023-151
|